A 2-(benzothiazol-2-yl)-phenolato platinum(II) complex as potential photosensitizer for combating bacterial infections in lung cancer chemotherapy†
Autor: | Begoña García, Natalia Busto, Christoph Janiak, José Ruiz, Cristina Pérez-Arnaiz, Venancio Rodríguez, Enrique Ortega |
---|---|
Rok vydání: | 2021 |
Předmět: |
Methicillin-Resistant Staphylococcus aureus
Platinum(II) complexes Lung Neoplasms Organoplatinum Compounds medicine.medical_treatment DMBA Photodynamic therapy Antineoplastic Agents medicine.disease_cause 01 natural sciences Chemistry Physical and theoretical 03 medical and health sciences Structure-Activity Relationship Drug Discovery medicine Química física Humans Photosensitizer Lung cancer Photodynamic inhibition 030304 developmental biology Pharmacology 0303 health sciences Photosensitizing Agents Dose-Response Relationship Drug Molecular Structure 010405 organic chemistry Chemistry Organic Chemistry Dual action agents Cancer General Medicine Bacterial Infections medicine.disease 0104 chemical sciences Anti-Bacterial Agents Staphylococcus aureus Cancer cell Cancer research Anticancer and antibacterial activity Phototoxicity |
Zdroj: | Repositorio Institucional de la Universidad de Burgos (RIUBU) Universidad de Burgos (UBU) Universidad de Cantabria (UC) |
Popis: | Cancer and antibiotic resistance are two global health threats that usually hamper clinical chemotherapeutic efficacy. Particularly for lung cancer, bacterial infections frequently arise thereby complicating the course of cancer treatment. In this sense, three new neutral luminescent cycloplatinated(II) photosensitizers of the type [Pt(dmba)(L)] (dmba = N,N-dimethylbenzylamine-κN,κC; L = 2-(benzo[d]oxazol-2-yl)-phenolato-κN,κO 1, 2-(benzo[d]thiazol-2-yl)-phenolato-κN,κO 2, and 2-(1-methyl-1H-benzo[d]imidazole-2-yl)phenolato-κN,κO 3) have been characterized and developed to potentially eliminate both resistant bacteria and lung cancer cells. The phototherapeutic effects of complex 2 have been evaluated using low doses of blue light irradiation. Complex 2 exerted promising photoactivity against pathogenic Gram-positive bacteria strains of clinical interest, displaying a phototoxic index (PI) of 15 for methicillin-resistant Staphylococcus aureus, one of the major microorganisms predominating lung infections. Likewise, the anticancer activity of 2 was also increased upon light irradiation in human lung A549 cancer cells (PI = 36). Further in vitro experiments with this platinum(II) complex suggest that ROS-generating photodynamic reactions were involved upon light irradiation, thus providing a reasonable mechanism for its dual anticancer and antibacterial activities. Spanish Ministerio de Ciencia e Innovación (MCI/AEI) and FEDER funds (Projects RTI2018-096891-B-I00, RTI2018-102040-B-100 and MultiMetDrugs network RED2018-102471-T), Consejería de Educación-Junta de Castilla y León-FEDER (BU042U16-BU305P18), “la Caixa” Banking Foundation (LCF/PR/PR12/11070003) and Fundación Séneca-Región de Murcia (Project 20857/PI/18). E.O. thanks AECC (PRDMU19003ORTE). Networking support by the COST Action CA18202 |
Databáze: | OpenAIRE |
Externí odkaz: |